Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
The Journal of Urology|June 28, 2017
High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical TrialTonye A Jones, Joseph Chin, David Mcleod, et al.
Clinical Endocrinology|February 28, 2018
The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular riskMartin Miner, Abraham Morgentaler, Mohit Khera, et al.
European Urology|September 15, 2004
Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasiaFrans Debruyne, Jack Barkin, Peter van Erps, et al.
BJU International|February 26, 2009
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trialJack Barkin, Claus G Roehrborn, Paul Siami, et al.
The Journal of Sexual Medicine|December 15, 2020
Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased RiskMohit Khera, Martin Miner, Jonathan Jaffe, et al.
The Canadian Journal of Urology|February 18, 2014
Prospective multi-center study elucidating patient experience after prostatic urethral liftNeal Shore, Sheldon Freedman, Steven Gange, et al.
The Journal of Urology|December 18, 2007
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT studyClaus G Roehrborn, Paul Siami, Jack Barkin, et al.
The Journal of Sexual Medicine|March 1, 2012
Cardiometabolic risk and female sexual health: the Princeton III summaryMartin Miner, Katherine Esposito, Andre Guay, et al.
BJU International|October 17, 2013
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT studyClaus G Roehrborn, Jack Barkin, Andrea Tubaro, et al.
BJU International|May 1, 2008
Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice settingMichael P O'Leary, John T Wei, Claus G Roehrborn, et al.
Pageof 17